Human Phenotype Ontology 
Grandparent Node:
expand
Anemia of inadequate production (HP:0010972)help
Parent Node:
expand
Sideroblastic anemia (HP:0001924)help
..Starting node
..expand
Pyridoxine-responsive sideroblastic anemia (HP:0005522)help
Term ID: 5522
Name: Pyridoxine-responsive sideroblastic anemia
Synonym: Pyridoxine-responsive sideroblastic anaemia
Definition: A type of sideroblastic anemia that is alleviated by pyridoxine (vitamin B-6) treatment.
Comments:
Reference: HP:0005522
Genes and Diseases:
 
       Child Nodes:

 Sister Nodes: 
..expandRefractory sideroblastic anemia (HP:0004864) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0005522HP:0005522Pyridoxine-responsive sideroblastic anemia0BRCA1 CL E G H6721100ORPHA:84Fanconi anemiaHP:0040281 - Very frequent5769
HP:0005522HP:0005522Pyridoxine-responsive sideroblastic anemia0BRCA2 CL E G H6751101ORPHA:84Fanconi anemiaHP:0040281 - Very frequent7642
HP:0005522HP:0005522Pyridoxine-responsive sideroblastic anemia0BRIP1 CL E G H8399020473ORPHA:84Fanconi anemiaHP:0040281 - Very frequent1086
HP:0005522HP:0005522Pyridoxine-responsive sideroblastic anemia0ERCC4 CL E G H20723436ORPHA:84Fanconi anemiaHP:0040281 - Very frequent158
HP:0005522HP:0005522Pyridoxine-responsive sideroblastic anemia0FANCA CL E G H21753582ORPHA:84Fanconi anemiaHP:0040281 - Very frequent340
HP:0005522HP:0005522Pyridoxine-responsive sideroblastic anemia0FANCB CL E G H21873583ORPHA:84Fanconi anemiaHP:0040281 - Very frequent58
HP:0005522HP:0005522Pyridoxine-responsive sideroblastic anemia0FANCC CL E G H21763584ORPHA:84Fanconi anemiaHP:0040281 - Very frequent410
HP:0005522HP:0005522Pyridoxine-responsive sideroblastic anemia0FANCD2 CL E G H21773585ORPHA:84Fanconi anemiaHP:0040281 - Very frequent147
HP:0005522HP:0005522Pyridoxine-responsive sideroblastic anemia0FANCE CL E G H21783586ORPHA:84Fanconi anemiaHP:0040281 - Very frequent73
HP:0005522HP:0005522Pyridoxine-responsive sideroblastic anemia0FANCF CL E G H21883587ORPHA:84Fanconi anemiaHP:0040281 - Very frequent87
HP:0005522HP:0005522Pyridoxine-responsive sideroblastic anemia0FANCG CL E G H21893588ORPHA:84Fanconi anemiaHP:0040281 - Very frequent73
HP:0005522HP:0005522Pyridoxine-responsive sideroblastic anemia0FANCI CL E G H5521525568ORPHA:84Fanconi anemiaHP:0040281 - Very frequent157
HP:0005522HP:0005522Pyridoxine-responsive sideroblastic anemia0FANCL CL E G H5512020748ORPHA:84Fanconi anemiaHP:0040281 - Very frequent53
HP:0005522HP:0005522Pyridoxine-responsive sideroblastic anemia0FANCM CL E G H5769723168ORPHA:84Fanconi anemiaHP:0040281 - Very frequent107
HP:0005522HP:0005522Pyridoxine-responsive sideroblastic anemia0MAD2L2 CL E G H104596764ORPHA:84Fanconi anemiaHP:0040281 - Very frequent1
HP:0005522HP:0005522Pyridoxine-responsive sideroblastic anemia0PALB2 CL E G H7972826144ORPHA:84Fanconi anemiaHP:0040281 - Very frequent1349
HP:0005522HP:0005522Pyridoxine-responsive sideroblastic anemia0PNPO CL E G H5516330260ORPHA:79096Pyridoxal phosphate-responsive seizuresHP:0040283 - Occasional92
HP:0005522HP:0005522Pyridoxine-responsive sideroblastic anemia0RAD51 CL E G H58889817ORPHA:84Fanconi anemiaHP:0040281 - Very frequent9
HP:0005522HP:0005522Pyridoxine-responsive sideroblastic anemia0RAD51C CL E G H58899820ORPHA:84Fanconi anemiaHP:0040281 - Very frequent391
HP:0005522HP:0005522Pyridoxine-responsive sideroblastic anemia0RFWD3 CL E G H5515925539ORPHA:84Fanconi anemiaHP:0040281 - Very frequent
HP:0005522HP:0005522Pyridoxine-responsive sideroblastic anemia0SLX4 CL E G H8446423845ORPHA:84Fanconi anemiaHP:0040281 - Very frequent274
HP:0005522HP:0005522Pyridoxine-responsive sideroblastic anemia0UBE2T CL E G H2908925009ORPHA:84Fanconi anemiaHP:0040281 - Very frequent2
HP:0005522HP:0005522Pyridoxine-responsive sideroblastic anemia0XRCC2 CL E G H751612829ORPHA:84Fanconi anemiaHP:0040281 - Very frequent125


Genes (23) :BRCA1 BRCA2 BRIP1 ERCC4 FANCA FANCB FANCC FANCD2 FANCE FANCF FANCG FANCI FANCL FANCM MAD2L2 PALB2 PNPO RAD51 RAD51C RFWD3 SLX4 UBE2T XRCC2

Diseases (2) :ORPHA:84 ORPHA:79096
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.